Rheumatoid Factors in Subacute Bacterial Endocarditis—Bacterium, Duration of Disease or Genetic Predisposition?

  1. RONALD P. MESSNER, M.D.;
  2. THROSTUR LAXDAL, M.D.;
  3. PAUL G. QUIE, M.D.; and
  4. RALPH C. WILLIAMS, JR., M.D.
  1. Requests for reprints should be addressed to Ralph C. Williams, Jr., M.D., Box 91, University of Minnesota Hospitals,
    Minneapolis, Minn. 55455
    .

SUMMARY

Forty-three patients with subacute bacterial endocarditis (SBE) were studied in an attempt to define what clinical features were important in the development of antigamma globulin factors during the course of their infection. Forty-seven percent showed positive latex fixation tests, and more than half showed some type of anti-gamma globulin factor during the course of their illness. A high degree of correlation between quantitative serum elevations of gamma G and positive test for rheumatoid factors was noted. However, the quantitative elevations of gamma G could not be directly related to infecting bacteria since absorption of sera with the latter produced no more than a 15% decrement in gamma G immunoglobulin. Most patients who developed positive latex fixation tests had a duration of active SBE greater than 6 weeks. An attempt was made to relate the development of a positive latex fixation test to genetic predisposition towards production of various autoantibodies. Kindreds from latex-positive and latex-negative patients with SBE showed no distinct differences in background autoantibodies to nuclear constituents, thyroglobulin, or gamma globulin. However, the most important factors in determining whether patients with SBE develop anti-gamma globulin factors appeared to be duration of infection and quantitative serum elevations of gamma G.

Article and Author Information

  • From the Arthritis Unit, Department of Medicine and Department of Pediatrics, University of Minnesota College of Medicine, University Hospitals, Minneapolis, Minn.

  • This study was supported by grants T1 AM 5461 and A1-06931, U. S. Public Health Service, Washington, D. C., by a grant from the Minnesota Arthritis Foundation, and conducted in part under the sponsorship of the Commission on Streptococcal and Staphylococcal Diseases, and supported by the Offices of the Surgeon General, Department of the Army, Washington, D. C.

    • Received November 13, 1967.
    • Accepted December 22, 1967.
« Previous | Next Article »Table of Contents